Document is current

Article History

Received: 4 March 2022

Revised: 13 September 2022

Accepted: 26 September 2022

First Online: 7 October 2022

Ethics approval and consent to participate

: This study was authorised by the French data protection authority ([Registration ID 1704113 and authorisation N_DE-2013.-117], NCT03275311). Moreover, in compliance with the applicable European regulations, a complementary authorisation was obtained for the ESME Data Warehouse on 14 October 2019. All data were obtained retrospectively, and no procedure was taken to recover unavailable data by contacting healthcare providers or patients. The present analysis was approved by an independent French ethics committee (Comité de Protection des Personnes Sud-Est II-2015–79).

: Not applicable.

: Dr. TDlMR reports personal fees and non-financial support from AstraZeneca, personal fees from Clovis oncology, personal fees from GSK, grant and personal fees from MSD, grant, personal fees and non-financial support from Pfizer, personal fees from Tesaro, personal fees and non-financial support from Roche Genentech, grant from SeattleGenetics, grant from Novartis, personal fees from Eisai, grant from Novartis, outside the submitted work. Dr. SD reports grants and non-financial support from Pfizer, grants from Novartis, grants and non-financial support from AstraZeneca, grants and non-financial support from Roche Genentech, grants from Lilly, grants from Puma, grants from Myriad, grants from Orion, grants from Amgen, grants from Sanofi, grants from Genomic Health, grants from GE, grants from Servier, grants from MSD, grants from BMS, grants from Pierre Fabre, grants from Seagen, grants from Exact Sciences, grants from Rappta, grants from Besins, grants from European Commission, grants from French government grants, grants from Fondation ARC, outside the submitted work. Dr. TF reports fees to its institution from Cellectis, grants from BMS, outside the submitted work. Dr. JSF reports personal fees from Roche Genentech, personal fees and non-financial support from SeattleGenetics, personal fees and non-financial support from Novartis, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Lilly, personal fees and non-financial support from Novartis, personal fees and non-financial support from GSK, personal fees and non-financial support from Clovis oncoloy, personal fees and non-financial support from AstraZeneca, personal fees and non-financial support from Daiichi Sankyo, personal fees and non-financial support from Gilead, personal fees and non-financial support from MSD, personal fees and non-financial support from Pierre Fabre, personal fees and non-financial support from Amgen, outside the submitted work. Dr. WJ reports grants, personal fees and non-financial support from AstraZeneca, personal fees and non-financial support from Eisai, personal fees and non-financial support from Novartis, personal fees and non-financial support from Roche, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Eli Lilly, personal fees from MSD, personal fees from BMS, personal fees and non-financial support from Chugai, personal fees from Seagen, grants and personal fees from Daiichi Sankyo, outside the submitted work. Dr. CL reports personal fees from Roche, non-financial support from MSD, grants from Lilly, other from DAIICHI, other from Pfizer, other from SANDOZ, outside the submitted work. Dr. AP reports other from Lilly, other from Pfizer, other from Pierre Fabre, others from Daiichi Sankyo, outside the submitted work. Dr. MR reports non-financial support from Roche, outside of the submitted work. Dr. JCT reports personal fees and non-financial support from PFIZER, personal fees from MSD, personal fees from ASTRA ZENECA, non-financial support from NOVARTIS, outside the submitted work. Dr. OT reports grants and personal fees from Roche, grants and personal fees from MSD-Merck, grants from BMS, personal fees from Novartis-Sandoz, personal fees from Pfizer, personal fees from Lilly, personal fees from AstraZeneca, personal fees from Daiichi Sankyo, personal fees from Eisai, personal fees from Pierre Fabre, personal fees from Seagen, personal fees from Gilead, outside the submitted work. Dr. CV reports personal fees from AstraZeneca, grants from BMS, non-financial support from IPSEN, personal fees from Novartis, personal fees and non-financial support from Pfizer, personal fees from Daiichi Sankyo, outside the submitted work. Drs. LC, OC, ID, AL, AM and LU have nothing to disclose.